Factors contributing to the growth of this market include the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology; and the increasing use of cold plasma in meat and poultry packaging decontamination.
The surface treatment segment accounted for the largest share of the cold plasma market for the polymer and plastic industry. This market segment is majorly driven by the advantages of cold plasma surface treatment, such as increased durability, better hydrophobic properties, higher packing density, better film quality, enhanced coating surface smoothness, and lower cost.
Wound healing is the fastest growing application segment in the cold plasma market for medical industry during the forecast period. The benefits of cold plasma technology in wound healing applications—faster healing and better results, sterilization efficiency, & cost-effectiveness as compared to conventional methods are driving the growth of this application segment.
In 2015, Europe accounted for the largest share of the global cold plasma market, followed by North America, Asia-Pacific, and RoW. The large share of Europe in the global market can be attributed to the presence of a large number of cold plasma companies and growing R&D work in Germany. The Asia-Pacific market is expected to register the highest growth during the forecast period, primarily due to the growing demand for cold plasma technology in China, India, Japan, and South Korea, among other APAC countries. Considering this factor, a majority of global companies are focusing on developing and expanding their R&D capabilities and distribution networks in this region.
Early buyers will receive 10% customization on this report – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=187065928
The major players in the cold plasma market are Nordson Corporation (U.S.), Bovie Medical Corporation (US), ADTEC Plasma Technology Co. Ltd. (Japan), Plasmatreat GmbH (Germany), Enercon Industries Corporation (US), Neoplas Tools GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Henniker Plasma (UK), and P2i Limited (UK).